Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 124 Records) |
| Query Trace: Disease and CYP3A4[original query] |
|---|
| [Influence of CYP3A4, CYP3A5, and NR3C1 genes polymorphism on the effectiveness of glucocorticoid therapy in patients with endocrine ophthalmopathy]. Vestnik oftalmologii 2020 12 136 (6. Vyp. 2): 125-132. Brovkina A F, Sychev D A, Toropova O |
| A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism. Annals of hematology 2020 Nov . Serin Istemi, Pehlivan Sacide, Gundes Ilknur, Fidan Oyaci Yasemin, Pehlivan Musta |
| Impact of CYP2D6, CYP3A5, and ABCB1 Polymorphisms on Plasma Concentrations of Donepezil and Its Metabolite in Patients With Alzheimer Disease. Therapeutic drug monitoring 2020 Oct . Kagawa Yoshiyuki, Yamamoto Yoshiaki, Ueno Ayami, Maeda Toshio, Obi Tomoka |
| Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania. Frontiers in pharmacology 2021 9 12 712084. Mnkugwe Rajabu Hussein, Minzi Omary, Kinung'hi Safari, Kamuhabwa Appolinary, Aklillu Ele |
| Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics. Medicinal research reviews 2021 6 41 (5): 2841-2886. Cacabelos Ramón, Carrera Iván, Martínez Olaia, Alejo Ramón, Fernández-Novoa Lucía, Cacabelos Pablo, Corzo Lola, Rodríguez Susana, Alcaraz Margarita, Nebril Laura, Tellado Iván, Cacabelos Natalia, Pego Rocío, Naidoo Vinogran, Carril Juan |
| Metabolizing profile of the cytochrome pathway CYP2D6, CYP3A4 and the ABCB 1 transporter in Spanish patients affected by Gaucher disease. Chemico-biological interactions 2021 May 109527. Almeida-Calpe A, López de Frutos L, Medrano-Engay B, García-García C B, Ribate M P, Giraldo |
| CYP2D6 and CYP3A4 variants influence the risk and outcome of COVID-19 infection among rheumatoid arthritis patients maintained on hydroxychloroquine. Drug metabolism and personalized therapy 2021 3 . Salem Hareedy Mohammad, Rashad Sonya Mohamed, Hetta Helal F, Hassanien Sara Mahmoud, Abdellatif Hebatallah, Hassanien Man |
| Physiologically-Based Pharmacokinetic-Pharmacodynamics Model Characterizing CYP2C19 Polymorphisms to Predict Clopidogrel Pharmacokinetics and Its Anti-Platelet Aggregation Effect Following Oral Administration to Coronary Artery Disease Patients With or Without Diabetes. Frontiers in pharmacology 2021 2 11 593982. Xu Ru-Jun, Kong Wei-Min, An Xiao-Fei, Zou Jian-Jun, Liu Li, Liu Xiao-Do |
| Role of Drug-Gene Interactions and Pharmacogenetics in Simvastatin-Associated Pulmonary Toxicity. Drug safety 2021 Oct . Jessurun Naomi T, Drent Marjolein, Wijnen Petal A, Harmsze Ankie M, van Puijenbroek Eugène P, Bekers Otto, Bast Aa |
| Influential Factors and Efficacy Analysis of Tacrolimus Concentration After Allogeneic Hematopoietic Stem Cell Transplantation in Children with ?-Thalassemia Major. Pharmacogenomics and personalized medicine 2021 10 14 1221-1237. Li Chengxin, Lu Jiejiu, Zhou Siru, Wei Yinyi, Lv Chunle, Liu Taotao, Wu Yun, Wu Dongni, Qi Jianying, Cai Rong |
| Pharmacogenetics of Praziquantel Metabolism: Evaluating the Cytochrome P450 Genes of Zimbabwean Patients During a Schistosomiasis Treatment. Frontiers in genetics 2022 6 13 914372. Zdesenko Grace, Mduluza Takafira, Mutapi Francis |
| Drug-Drug Interactions and Disease Status Are Associated With Irinotecan-Induced Hepatotoxicity: A Cross-Sectional Study in Shanghai. Journal of clinical pharmacology 2022 4 62 (9): 1160-1169. Li Juan, Chen Bing, Xi Wen-Qi, Jia Wan, Zhang Wei-Xia, Bian Xiao-L |
| Evaluation of the Association between Single Nucleotide Polymorphisms of Metabolizing Enzymes with the Serum Concentration of Paracetamol and Its Metabolites. Metabolites 2022 12 12 (12): . Sridharan Kannan, Qader Ali Mohamed, Hammad Mustafa, Jassim Anfal, Diab Diab Eltayeb, Abraham Betsy, Hasan Hasan M S N, Pasha Sheikh Abdul Azeez, Shah Sham |
| Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer's Disease. Dementia and geriatric cognitive disorders extra 0 11 (3): 264-272. Kagawa Yoshiyuki, Yamamoto Yoshiaki, Ueno Ayami, Inomata Kengo, Tezuka Mayu, Osawa Takashi, Yazawa Yasuharu, Maeda Toshio, Obi Tomoka |
| CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride. Clinical and translational science 2022 Sep . Campodónico Diana María, Zubiaur Pablo, Soria-Chacartegui Paula, Casajús Ana, Villapalos-García Gonzalo, Navares-Gómez Marcos, Gómez-Fernández Antía, Parra-Garcés Raúl, Mejía-Abril Gina, Román Manuel, Martín-Vílchez Samuel, Ochoa Dolores, Abad-Santos Francis |
| Evaluation of Human Hepatocyte Drug Metabolism Carrying High-Risk or Protection-Associated Liver Disease Genetic Variants. International journal of molecular sciences 2023 9 24 (17): . Lanuza A P Faccioli, Zeliha Cetin, Zehra N Kocas-Kilicarslan, Kimberly Ortiz, Yiyue Sun, Zhiping Hu, Takeshi Kurihara, Edgar N Tafaleng, Rodrigo M Florentino, Zi Wang, Mengying Xia, Mark T Miedel, D Lansing Taylor, Jaideep Behari, Alina Ostrowska, Robert Constantine, Albert Li, Alejandro Soto-Gutierr |
| Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphisms. British journal of clinical pharmacology 2023 7 . Ayako Oda, Yosuke Suzuki, Chisato Yoshijima, Haruki Sato, Ryota Tanaka, Hiroyuki Ono, Ryosuke Tatsuta, Tadasuke Ando, Toshitaka Shin, Hiroki Itoh, Keiko Oh |
| VARIANTS OF THE FORMATION AND COURSE OF DRUG-RESISTANT EPILEPSY IN CHILDREN WITH GENETIC POLYMORPHISMS OF CYP2C9, CYP2C19, CYP3A4. Wiadomosci lekarskie (Warsaw, Poland : 1960) 2023 6 76 (5 pt 1): 1007-1013. Liudmyla M Tantsura, Olena Yu Pylypets, Dmytro V Tretiakov, Yevhen O Tantsu |
| The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 2023 6 . Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte, Michela Guardascione, Martina Zanchetta, Bianca Posocco, Marco Orleni, Giovanni Canil, Rossana Roncato, Erika Cecchin, Giuseppe Toffo |
| Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancer. EClinicalMedicine 2023 5 59 101955. G D Marijn Veerman, Rene J Boosman, Merel Jebbink, Esther Oomen-de Hoop, Anthonie J van der Wekken, Idris Bahce, Lizza E L Hendriks, Sander Croes, Christi M J Steendam, Evert de Jonge, Stijn L W Koolen, Neeltje Steeghs, Ron H N van Schaik, Egbert F Smit, Anne-Marie C Dingemans, Alwin D R Huitema, Ron H J Mathijss |
| Retrospective pharmacogenetic study in a cohort of pediatric tuberous sclerosis complex patients using everolimus. Pharmacogenomics 2023 10 . Julia Concha, Estela Sangüesa, Jose Luis Peña, María Pilar Ribate, Cristina Belén Garc |
| Pharmacogenetics of anxiety and depression in Alzheimer's disease. Pharmacogenomics 2023 1 24 (1): 27-57. Cacabelos Ramón, Carril Juan C, Corzo Lola, Pego Rocío, Cacabelos Natalia, Alcaraz Margarita, Muñiz Adriana, Martínez-Iglesias Olaia, Naidoo Vinogr |
| Effects of CYP3A5 Genotype on Tacrolimus Pharmacokinetics and Graft-versus-Host Disease Incidence in Allogeneic Hematopoietic Stem Cell Transplantation. Pharmaceuticals (Basel, Switzerland) 2024 5 17 (5): . Daniel N Marco, Mònica Molina, Ana-María Guio, Judit Julian, Virginia Fortuna, Virginia-Lucila Fabregat-Zaragoza, María-Queralt Salas, Inés Monge-Escartín, Gisela Riu-Viladoms, Esther Carcelero, Joan Ramón Roma, Noemí Llobet, Jordi Arcarons, María Suárez-Lledó, Laura Rosiñol, Francesc Fernández-Avilés, Montserrat Rovira, Mercè Brunet, Carmen Martín |
| Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study. Gynecologic oncology 2024 5 187 139-144. M Zenatri, T Perennec, C Michon, F Gernier, J-M Grellard, F-X Piloquet, C Dubot-Poitelon, E Kalbacher, O Tredan, P Augereau, P Pautier, L Fey, F Joly, J-S Fren |
| Impact of STAT6 Variants on the Response to Proton Pump Inhibitors and Comorbidities in Patients with Eosinophilic Esophagitis. International journal of molecular sciences 2024 4 25 (7): . Paula Soria-Chacartegui, Marcos Navares-Gómez, Francisca Molina-Jiménez, Emilio J Laserna-Mendieta, Laura Arias-González, Pedro Majano, Sergio Casabona, Alfredo J Lucendo, Francisco Abad-Santos, Cecilio Santander, Pablo Zubia |
| [Glucocorticoid-resistant forms of endocrine ophthalmopathy]. Vestnik oftalmologii 2024 12 140 (6): 125-130. A F Brovki |
| Exploring the associations of plasma proteins with frailty based on Mendelian randomization. BMC immunology 2024 12 25 (1): 86. Shuhui Chen, Hao Lin, Bin Liu, Hejing Pan, Yaling Xu, Yingying Mao, Lin Hua |
| Increased plasma imatinib exposure and toxicity in chronically treated GIST patients with SARS-CoV-2 infection: a case series. Frontiers in immunology 2024 10 15 1441620. Sara Gagno, Bianca Posocco, Marco Orleni, Eleonora Cecchin, Arianna Fumagalli, Michela Guardascione, Angela Buonadonna, Jerry Polesel, Fabio Puglisi, Giuseppe Toffoli, Erika Cecch |
| Association between CYP3A4, CYP3A5 and ABCB1 genotype and tacrolimus treatment outcomes among allogeneic HSCT patients. Pharmacogenomics 2024 1 . Teresa T Ho, Janelle B Perkins, Rebecca Gonzalez, James Kevin Hicks, Ronald Alvarez Martinez, Katie Duranceau, Brianna North, Jongphil Kim, Jamie K Teer, Jiqiang Yao, Sean J Yoder, Taiga Nishihori, Nelli Bejanyan, Joseph Pidala, Hany Elmari |
| CYP3A5 influences oral tacrolimus pharmacokinetics and timing of acute kidney injury following allogeneic hematopoietic stem cell transplantation. Frontiers in pharmacology 2024 1 14 1334440. Nathan D Seligson, Xunjie Zhang, Mark C Zemanek, Jasmine A Johnson, Zachary VanGundy, Danxin Wang, Mitch A Phelps, Julianna Roddy, Craig C Hofmeister, Junan Li, Ming J P |
- Page last reviewed:Feb 1, 2024
- Content source: